Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 536,874,400
  • Shares Outstanding, K 8,650
  • 60-Month Beta 0.70
  • Price/Earnings ttm 16.55
  • Annual Dividend & Yield 1.16 (1.86%)
  • Most Recent Dividend 0.292 on 03/18/25
  • Management Fee 0.39%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 20.33% ( +3.26%)
  • Historical Volatility 37.35%
  • IV Percentile 79%
  • IV Rank 40.36%
  • IV High 49.42% on 04/09/25
  • IV Low 0.64% on 10/15/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 3.52
  • Today's Open Interest 199
  • Open Int (30-Day) 155

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.64 +3.23%
on 04/16/25
68.47 -7.07%
on 04/30/25
+0.68 (+1.08%)
since 04/15/25
3-Month
58.97 +7.90%
on 04/09/25
73.28 -13.17%
on 03/03/25
-6.14 (-8.80%)
since 02/14/25
52-Week
58.97 +7.90%
on 04/09/25
73.28 -13.17%
on 03/03/25
-2.81 (-4.23%)
since 05/15/24

Most Recent Stories

More News
Do Wall Street Analysts Like Viatris Stock?

Viatris has underperformed the broader market over the past year, and analysts remain skeptical of the stock’s future potential.

$SPX : 5,916.93 (+0.41%)
VTRS : 8.79 (+4.39%)
IHE : 63.63 (+2.53%)
JEF : 53.41 (-1.53%)
Are Wall Street Analysts Bullish on Merck Stock?

While Merck has trailed the broader market over the past year, analysts still see a reasonably promising path ahead for the pharma heavyweight.

$SPX : 5,916.93 (+0.41%)
MRK : 74.80 (+1.81%)
IHE : 63.63 (+2.53%)
Are Wall Street Analysts Bullish on Walgreens Boots Stock?

Walgreens Boots has underperformed the broader market over the past year, and analysts remain skeptical about the stock's prospects.

$SPX : 5,916.93 (+0.41%)
WBA : 11.18 (+0.45%)
IHE : 63.63 (+2.53%)
DB : 28.23 (+1.62%)
Are Wall Street Analysts Bullish on Bristol-Myers Stock?

Bristol-Myers has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

$SPX : 5,916.93 (+0.41%)
IHE : 63.63 (+2.53%)
MRK : 74.80 (+1.81%)
PIPR : 265.46 (+0.22%)
BMY : 45.81 (+3.83%)
How Is Gilead Sciences' Stock Performance Compared to Other Pharmaceutical Stocks?

As Gilead Sciences has outperformed its industry peers recently, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

IHE : 63.63 (+2.53%)
GILD : 100.34 (+1.99%)
AMGN : 271.69 (+3.59%)
How Is Pfizer's Stock Performance Compared to Other Pharmaceuticals Stocks?

Pfizer has underperformed the pharmaceuticals industry over the past year, but analysts are moderately optimistic about the stock’s prospects.

IHE : 63.63 (+2.53%)
PFE : 22.60 (+2.63%)
BMY : 45.81 (+3.83%)
What Are Wall Street Analysts’ Target Price for Merck Stock?

Merck has considerably underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

$SPX : 5,916.93 (+0.41%)
MRK : 74.80 (+1.81%)
IHE : 63.63 (+2.53%)
ETFs Poised to Win or Lose Under Trump's New Policies

On Jan. 20, President Donald Trump commenced his second term by enacting a series of executive orders and repealing dozens of directives issued by former president Joe Biden, aimed at reshaping various...

XLE : 85.61 (+0.42%)
PBW : 18.42 (-0.75%)
IHE : 63.63 (+2.53%)
CARZ : 57.94 (-2.16%)
DRIV : 22.59 (-0.66%)
BITQ : 16.23 (-2.87%)
ICLN : 13.00 (+0.54%)
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip

Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected sales for its weight-loss medicine...

OZEM : 23.51 (+1.16%)
IHE : 63.63 (+2.53%)
LLY : 733.29 (+2.48%)
MEDX : 25.26 (+1.90%)
PPH : 84.94 (+2.63%)
THNR : 21.40 (+1.32%)
Eli Lilly Stock: Is Wall Street Bullish or Bearish?

Eli Lilly has outperformed the broader market and its peers this year, and Wall Street analysts are bullish about the stock’s prospects.

$SPX : 5,916.93 (+0.41%)
IHE : 63.63 (+2.53%)
LLY : 733.29 (+2.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Key Turning Points

3rd Resistance Point 65.25
2nd Resistance Point 64.44
1st Resistance Point 64.03
Last Price 63.63
1st Support Level 62.82
2nd Support Level 62.01
3rd Support Level 61.61

See More

52-Week High 73.28
Fibonacci 61.8% 67.81
Fibonacci 50% 66.13
Fibonacci 38.2% 64.44
Last Price 63.63
52-Week Low 58.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar